Pulling SEC filings + quote and writing the call…

Heartflow, Inc.
Next earnings Sep 17, 2026 · consensus $-0.14 EPS, $57.9M rev
Last earnings +3.3% on 2026-05-14
Revenue grew 39.9% YoY; but unprofitable (net margin -66.3%).
Heartflow, Inc. shows $176M in FY2025 revenue (+39.9% YoY), a -66.3% net margin, and -38.8% ROE.
| Line item | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue | $87.2M | $126M | $176M |
| Gross profit | $58.1M | $94.4M | $135M |
| Operating income | -$72.9M | -$61.2M | -$64.1M |
| Net income | -$95.7M | -$96.4M | -$117M |
| Diluted EPS | -$25.32 | -$17.98 | -$3.17 |
| Net margin | -109.7% | -76.6% | -66.3% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Sources: SEC EDGAR (CIK 0001464521, latest 10-Q filed 2026-05-14) · EODHD · as of 6/26/2026, 6:15:13 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 1 sale
| 2026-06-24 | Farquhar John C.M. Chief Executive Officer | Sell | 38.9K @ $35.00 | $1.36M |
| 2026-06-15 | Rogers Campbell Chief Medical Officer | Exercise | 10.0K @ $2.22 | $22.2K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1044 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.